Quarterly report pursuant to sections 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Condensed Consolidated Statements Of Operations    
REVENUES $ 792,935 $ 4,400
Cost of sales 529,046 2,200
Gross profit 263,889 2,200
Research and development 1,467,584 81,820
Plasma center 515,288 459,293
General and administrative expenses 1,431,106 674,589
TOTAL OPERATING EXPENSES 3,413,978 1,215,702
LOSS FROM OPERATIONS (3,150,089) (1,213,502)
Interest income 510 7,067
Interest expense (128,796) (8,494)
Change in fair value of stock warrants 36,728 0
TOTAL OTHER INCOME (EXPENSE) (91,558) (1,427)
LOSS BEFORE INCOME TAXES (3,241,647) (1,214,929)
State income tax benefit 0 617,615
NET LOSS $ (3,241,647) $ (597,314)
NET LOSS PER SHARE - BASIC AND DILUTED $ (0.55) $ (0.18)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, Basic and Diluted 5,871,002 3,363,069